Status:
RECRUITING
Employment Support After Hematopoietic Stem Cell Transplantation
Lead Sponsor:
MGH Institute of Health Professions
Collaborating Sponsors:
Massachusetts General Hospital
Conditions:
Hematopoietic Stem Cell Transplantation
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
This is a feasibility study of a Work Support (WorkS) intervention designed to ameliorate employment challenges for people preparing to return to work after allogeneic stem cell transplantation. The a...
Detailed Description
Participants will be recruited from MGH Cancer Center. The intervention will be delivered at MGH Institute of Health Professions (IHP) and investigators at MGH IHP will be involved in recruiting parti...
Eligibility Criteria
Inclusion
- Received an allogeneic HSCT within the past six months to treat a hematological malignancy.
- Screen positive for work-related concerns (i.e., responds "yes" to the question, "Are you concerned about your ability to return to work in the coming six months?")
Exclusion
- Patients with acute psychiatric or cognitive conditions which the treating clinician believes prohibits informed consent or compliance with the study procedures
- We will not enroll the following special populations: adults unable to consent, individuals not yet adults, pregnant women, and prisoners.
Key Trial Info
Start Date :
July 31 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT06494423
Start Date
July 31 2024
End Date
December 31 2027
Last Update
December 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MGH Cancer Center
Boston, Massachusetts, United States, 02114